WuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive Year Ranked among the top 1% of companies assessed in the pharmaceutical industry… CISION PRNewswireFebruary 10, 2025
Press ReleaseCNN's The Journey Matters explores the diverse cultures and communities of picturesque Philippines HONG KONG, Feb. 10, 2025 /PRNewswire/ — Join The Journey Matters as… CISION PRNewswireFebruary 10, 2025
Press ReleaseISLE 2025 to Open on March 7: Global Innovation & Production Hub of LED Display & Integrated System SHENZHEN, China, Feb. 10, 2025 /PRNewswire/ — ISLE 2025, Asia’s biggest exhibition… CISION PRNewswireFebruary 10, 2025
Global Times: From regional specialty to global delicacy, roujiamo bridges cultures, makes Chinese cuisine international BEIJING, Feb. 10, 2025 /PRNewswire/ — In September 2024, a giant billboard… CISION PRNewswireFebruary 10, 2025
BioRay's ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA SHANGHAI, Feb. 10, 2025 /PRNewswire/ — On December 19, 2024, BioRay Pharmaceutical… CISION PRNewswireFebruary 10, 2025
Meeting Australia's Growing Demand for Sustainable Tissue Products: APP Group and Sorbent Paper Lead the Charge JAKARTA, Indonesia, Feb. 10, 2025 /PRNewswire/ — Consumer demands in Australia have… CISION PRNewswireFebruary 10, 2025
Press ReleaseAddress Advisors Setting Benchmarks for GCC's Real Estate Solutions in India SINGAPORE and BENGALURU, India, Feb. 10, 2025 /PRNewswire/ — Address Advisors, a… CISION PRNewswireFebruary 10, 2025
Caliway Announces CBL-514 Second Phase 2b Study Results (CBL-0205) Met Endpoints CBL-514, the world’s first investigational drug for large-area localized fat reduction, has… CISION PRNewswireFebruary 10, 2025
